News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Marija Balic, MD, discusses how circulating tumor DNA assays for molecular residual disease detection have evolved in recent ...
Zacks Investment Research on MSN
FLGT to acquire Bako & StrataDx assets to expand pathology platform
Fulgent Genetics, Inc. FLGT recently entered into an agreement to acquire selected assets of Bako Diagnostics and to acquire ...
Hepatitis C is a tiny virus with a significant impact. It's a small RNA virus that spreads through the blood and infects the liver. Even though today's medicines can cure it, hepatitis C remains a ...
We searched for evidence from studies known as 'clinical trials' that compared rapid TB tests with traditional methods of testing for TB, like smear microscopy and culture. We summarised the findings ...
The diagnostic armamentarium for solid tumors is evolving rapidly, redefining how we detect, stage, stratify, monitor, and ultimately treat cancer. This ...
The firm's Phase I/II study yielded responses in mCRPC patients with androgen receptor mutations but it wasn't as promising in HR-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback